Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pcoopman
Group name EquipePC
Item Type Journal Article
Title Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
Creator Bellanger et al.
Author Aurélie Bellanger
Author Diep T. Le
Author Julie Vendrell
Author Anne Wierinckx
Author L?rinc S. Pongor
Author Jérôme Solassol
Author Joël Lachuer
Author Philippe Clezardin
Author Balázs Gy?rffy
Author Pascale A. Cohen
Abstract Oncogene alternative splicing events can create distinct functional transcripts that offer new candidate prognostic biomarkers for breast cancer. ZNF217 is a well-established oncogene but its exon 4-skipping isoform (ZNF217-?E4) has never been investigated in terms of clinical or biological relevance. Using in silico RNA-seq and RT-qPCR analyses, we demonstrated for the first time the existence of ZNF217-?E4 transcripts in primary breast tumors, and a positive correlation between ZNF217-?E4 mRNA levels and those of the wild-type oncogene (ZNF217-WT). A pilot retrospective analysis revealed that, in the Luminal subclass, the combination of the two ZNF217 variants (the ZNF217-?E4-WT gene-expression signature) provided more information than the mRNA expression levels of each isoform alone. Ectopic overexpression of ZNF217-?E4 in breast cancer cells promoted an aggressive phenotype and an increase in ZNF217-WT expression levels that was inversely correlated with DNA methylation of the ZNF217 gene. This study provides new insights into the possible role of the ZNF217-?E4 splice variant in breast cancer and suggests a close interplay between the ZNF217-WT and ZNF217-?E4 isoforms. Our data suggest that a dual signature combining the expression levels of these two isoforms may serve as a novel prognostic biomarker allowing better stratification of breast cancers with good prognosis and aiding clinicians in therapeutic decisions.
Publication Frontiers in Oncology
Volume 11
Pages 647269
Date 2021
Journal Abbr Front Oncol
Language eng
DOI 10.3389/fonc.2021.647269
ISSN 2234-943X
Library Catalog PubMed
Extra PMID: 34277402 PMCID: PMC8283766
Tags breast cancer, clinic, isoform, splice variant, ZNF217
Date Added 2023/11/20 - 17:10:00
Date Modified 2023/11/20 - 17:13:10
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés